Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

121.59 -2.87 (-2.31%)
Streaming Delayed Price Updated: 2:17 PM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 421,583
Open 123.09
Bid (Size) 121.57 (2)
Ask (Size) 121.67 (1)
Prev. Close 124.46
Today's Range 120.82 - 124.74
52wk Range 89.00 - 229.58
Shares Outstanding 146,700,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The Cathie Wood Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving
Investing with the Ark Invest guru is a roller coaster ride, but she always keeps her big ideas for the future in front of her. 
Via InvestorPlace
Looking Into Illumina's Recent Short Interest
Via Benzinga

Performance

YTD
-11.64%
-11.64%
1 Month
-9.30%
-9.30%
3 Month
-13.61%
-13.61%
6 Month
+4.73%
+4.73%
1 Year
-46.92%
-46.92%

More News

Read More
Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy'
Via Benzinga
Nasdaq’s Nosebleed Section: 3 Expensive Stocks to Sell Before It’s Too Late
Via InvestorPlace
Leading the Way: Swoop Named Provider of Choice for Employee Shuttling by Fortune 500 & Renowned Technology Companies
Via PRLog
Critical Insights From Illumina Analyst Ratings: What You Need To Know
Via Benzinga
Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers Over The Past 12 Months
Via Talk Markets
Why Illumina Stock Zoomed Higher on Thursday
Via The Motley Fool
EU Antitrust Regulators Overstepped in Illumina-Grail Deal, Says Court Adviser
Via Benzinga
Icahn’s All-In: 3 Stocks Billionaire Carl Icahn Is Betting Big On
Via InvestorPlace
Gene Sequencing Firm Illumina Escapes Carl Icahn's Second Proxy Battle Amid Grail Divestment Efforts
Via Benzinga
Earnings Crushers: Unveiling Q4’s 3 Top Stock Superstars
Via InvestorPlace
3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
Via InvestorPlace
7 No-Frills Dividend Stocks for Your Must-Own List
Via InvestorPlace
Over $1M Bet On This Industrial Stock? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
ILLUMINA ALERT: Bragar Eagel & Squire, P.C. is Investigating Illumina, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Why Illumina Stock Mashed the Market on Monday
Via The Motley Fool
Activist Investor Alert: The Top 3 Stocks Carl Icahn Is Targeting in 2024
Via InvestorPlace
3 Gene Editing Stocks With Unprecedented Surge Potential
Via InvestorPlace
DNA Sequencing Kit Provider Illumina's Q4 Earnings Edge Above Street Estimates, Works To Resolve GRAIL Quickly
Via Benzinga
US Stocks Set To Open Higher, Finish Week Stronger Amid Mixed Earnings: Analyst Sees Another Leg-Up Ahead Of Historically Weak March
Via Benzinga
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Expedia Reports Q4 Results, Joins Pinterest, Affirm Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
S&P 500 Tests Resistance At 5,000, ARM Rockets, Oil Rebounds: What's Driving Markets Thursday?
Via Benzinga
Topics Stocks
Exposures US Equities
US Stocks On Backfoot Amid Overbought Levels, S&P 500 Eyes Break Above 5K: Analyst Sees 'Dramatically Higher' Market Surge From Rally This Year
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.